Dec 28 (Reuters) - Gw Pharmaceuticals Plc:
* GW PHARMACEUTICALS ANNOUNCES ACCEPTANCE OF NDA FILING FOR EPIDIOLEX® (CANNABIDIOL) IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME AND DRAVET SYNDROME Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.